For HER2+ gastric cancer, the high expression of VIM, IFI44, IFI44L, IFIT2, IFIT3, ISG15, OAS1, or OASL was associated with worse overall survival (P < 0.05) (Figure 3(d) and Table 3). The gene discussed is ERBB2; the disease is gastric cancer.